JORDAN SPOON: Open Payments
NPI 1265807770 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,019 in 76 payments from 16 companies in 2025. Trend: 2023 $3,721 · 2024 $3,516 · 2025 $2,019
Food & beverage: $1,839Education: $180
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $336 |
| GENZYME CORPORATION | 4 | $299 |
| Arcutis Biotherapeutics, Inc. | 12 | $200 |
| ABBVIE INC. | 6 | $199 |
| Lilly USA, LLC | 2 | $148 |
| E.R. Squibb & Sons, L.L.C. | 20 | $143 |
| UCB, Inc. | 6 | $138 |
| Journey Medical Corporation | 1 | $117 |
| LEO Pharma Inc. | 5 | $106 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $100 |
Products named: TREMFYA, DUPIXENT, Zoryve, Sotyktu, Bimzelx, EBGLYSS, ADBRY, VTAMA.
Industry payments across NV — which companies pay providers there.
